OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation
Radwa Ayman, A. M. Radwan, Amira M. Elmetwally, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Synthesis, structural, molecular docking, and in vitro biological activities of Cu-doped ZnO nanomaterials
Ahmed F. El‐Sayed, Wael M. Aboulthana, Marwa A. Sherief, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16

Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent
Abdulrahman A. Almehizia, Ahmed M. Naglah, Sadeem S. Aljafen, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 180-180
Open Access | Times Cited: 2

In vitro enzymatic evaluation of some pyrazolo[1,5‐a]pyrimidine derivatives: Design, synthesis, antioxidant, anti‐diabetic, anti‐Alzheimer, and anti‐arthritic activities with molecular modeling simulation
Ashraf S. Hassan, Nesrin M. Morsy, Wael M. Aboulthana, et al.
Drug Development Research (2022) Vol. 84, Iss. 1, pp. 3-24
Closed Access | Times Cited: 62

A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5-b]quinoxaline derivatives hybrid with a sulfonamide moiety
Mostafa A. Ismail, Moustafa S. Abusaif, M. S. A. El‐Gaby, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12589-12608
Open Access | Times Cited: 25

Evaluation of the anti-proliferative activity of 2-oxo-pyridine and 1′H-spiro-pyridine derivatives as a new class of EGFRWt and VEGFR-2 inhibitors with apoptotic inducers
Reham R. Raslan, Yousry A. Ammar, Sawsan A. Fouad, et al.
RSC Advances (2023) Vol. 13, Iss. 15, pp. 10440-10458
Open Access | Times Cited: 24

In vitro biological studies and computational prediction-based analyses of pyrazolo[1,5-a]pyrimidine derivatives
Abdulrahman A. Almehizia, Wael M. Aboulthana, Ahmed M. Naglah, et al.
RSC Advances (2024) Vol. 14, Iss. 12, pp. 8397-8408
Open Access | Times Cited: 15

Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α‐glucosidase, α‐amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation
Ahmed Ragab, Mohamed A. Salem, Yousry A. Ammar, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 10

Bioactive Fused Pyrazoles Inspired by the Adaptability of 5-Aminopyrazole Derivatives: Recent Review
Dana M. Odeh, Mohanad Odeh, Taghrid S. Hafez, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 366-366
Open Access | Times Cited: 1

Development of new spiro[1,3]dithiine-4,11′-indeno[1,2-b]quinoxaline derivatives as S. aureus Sortase A inhibitors and radiosterilization with molecular modeling simulation
Ahmed Ragab, Moustafa S. Abusaif, Nirvana A. Gohar, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106307-106307
Closed Access | Times Cited: 35

Novel Water-soluble quinoxaline-2,3-dione-6-sulfohydrazide derivatives as efficient acid corrosion inhibitors: Design, characterization, experimental, and theoretical studies
Moustafa S. Abusaif, Amira M. Hyba, Yousry A. Ammar, et al.
Journal of the Taiwan Institute of Chemical Engineers (2023) Vol. 153, pp. 105207-105207
Closed Access | Times Cited: 22

Developing a new multi-featured chitosan-quinoline Schiff base with potent antibacterial, antioxidant, and antidiabetic activities: design and molecular modeling simulation
Yasser M. Abdel-Baky, Ahmed M. Omer, Esmail M. El‐Fakharany, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20

New prospective insecticidal agents based on thiazolo[4,5-b]quinoxaline derivatives against cotton leafworm Spodoptera litura (Fabricius): Design, synthesis, toxicological, morphology, histological, and biomedical studies
Ahmed Ragab, Doaa M. Elsisi, Enayat M. Elqady, et al.
Pesticide Biochemistry and Physiology (2024) Vol. 202, pp. 105943-105943
Closed Access | Times Cited: 8

Evaluation of the biological efficiency of Terminalia chebula fruit extract against neurochemical changes induced in brain of diabetic rats: an epigenetic study
Marwa E. A. El-Shamarka, Wael M. Aboulthana, Nagwa Omar, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1439-1460
Open Access | Times Cited: 7

Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus
Hamdy Khamees Thabet, Moustafa S. Abusaif, Mohd Imran, et al.
Computational Biology and Chemistry (2024) Vol. 111, pp. 108097-108097
Closed Access | Times Cited: 7

In silico approach to design new cyclooxygenase-2 (COX-2) inhibitors based on MM/QM and ADMET analysis
Ashutosh Kharwar, Akanksha Mishra, Vijay Kumar Singh, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100509-100509
Open Access | Times Cited: 6

Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation
Hamdy Khamees Thabet, Ahmed Ragab, Mohd Imran, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116589-116589
Closed Access | Times Cited: 6

Synthesis, antimicrobial activity and molecular docking studies of spiroquinoline-indoline-dione and spiropyrazolo-indoline-dione derivatives
Melek Gül, Emine Çelikoğlu, Önder İdil, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16

Development of pyrazolo[1,5-a]pyrimidine-based antibacterial agents
Ahmed E. M. Mekky, N. Taha, Nada G. Mohammed, et al.
Synthetic Communications (2023) Vol. 53, Iss. 13, pp. 1053-1068
Closed Access | Times Cited: 13

Potential MRSA inhibitory activity of some new benzofuran-pyrazolo[1,5- a ]pyrimidine hybrids attached to arene units via methylene or azo linkage
Sherif M. H. Sanad, Ahmed E. M. Mekky
Synthetic Communications (2024), pp. 1-14
Closed Access | Times Cited: 5

Synthesis of new bis(pyrazolo[1,5- a ]pyrimidines) linked to different spacers with potential MurB inhibitory activity utilizing 1 H -pyrazole-3,5-diamines
A.A. Ahmed, Ahmed E. M. Mekky, Sherif M. H. Sanad
Synthetic Communications (2024), pp. 1-13
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top